Demecillo, Romeo D.
HRN: 23-06-79 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/25/2023
06/01/2023
IV
1.5 Grams
Q8H
T/c Soft Tissue Infection
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes